Widely read:
The Exchange has sought clarification from Aurobindo Pharma Ltd on February 18 2026 with reference to news appeared in https://www.ndtvprofit.com/ dated February 18 2026 quoting "Aurobindo Pharma Shares Fall After USFDA Flags Severe Contamination Data Integrity Failures"
The reply is awaited.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
